Bepridil
Bepridil is an amine calcium channel blocker once used to treat angina. It is no longer sold in the United States.
It is nonselective.
It has been discussed as a possible option in the treatment of atrial fibrillation.
It has been implicated in causing ventricular arrhythmia.In June 2015 a research paper was published finding bepridil to result in a 100% survival rate for mice exposed to ebola during an experiment searching for potential pharmaceutical ebola treatments; indicating its potential use in future ebola research and therapy.
